Impact Factor
2.48
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.28
2,669 total citations
h5-index
56
h5 depth signal
Cited share
11.2%
1,084 of 9,666
Total citations
2,669
Citation footprint
Metric signal
0.34
External metric anchor
Self-citation
7.6%
202 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
3,592
United Kingdom
1,713
Canada
604
China
604
Netherlands
544
Citing Fields of Research
Medical Ethics
9,940
Healthcare Policy
9,443
Oncology
4,678
Patient Care
2,997
Musculoskeletal Disorders
2,731
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
79,872
Articles tracked across the journal lifetime
Indexed publication set
9,666
1,084 cited publications
Last 12 months
4,847
403.9 publications/month
Open access share
2.8%
135 OA publications in the last year
Leading citing country
United States
3,592 citing publications
Leading citing field
Medical Ethics
9,940 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Jan.-Feb. 2001-
v4n1, Jan.-Feb. 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Medical Ethics
Healthcare Policy
Oncology
Diabetes
Musculoskeletal Disorders
Hematology
Issuing & Sponsoring Bodies
Contributor
International Society for Pharmacoeconomics and Outcomes Research
Broad Categories
Drug Therapy
Public Health
Medical Ethics
Hematology
Musculoskeletal Disorders
Genetics & Genomics
Cardiology
HIV
Diabetes
MeSH Descriptors
Biomedical Technology
Economics, Pharmaceutical
Health Resources
Outcome Assessment, Health Care
Risk Assessment
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.jval.2026.09.3129
Open DOI
Individualized Prediction of Patient-Defined Treatment Success to Support Patient-Centered Clinical Decision-Making
02
DOI 10.1016/j.jval.2026.10.003
Open DOI
Why Bayesian Nonparametric Models Should Be a First-Line Approach for Health State Valuations
03
DOI 10.1016/j.jval.2026.09.3128
Open DOI
Sleep and fatigue/energy bolt-ons for the EQ-5D-3L and EQ-5D-5L: a systematic review
04
DOI 10.1016/j.jval.2026.07.015
Open DOI
Beyond Preference Heterogeneity: Toward Biobehavioral Stratification in Digital Neurorehabilitation
05
06
DOI 10.1016/j.jval.2026.10.001
Open DOI
Author Reply
07
DOI 10.1016/j.jval.2026.09.3127
Open DOI
Cost-effectiveness of insulin regimens and insulin types for adults with type 1 diabetes: a systematic review
08
DOI 10.1016/j.jval.2026.08.015
Open DOI
Health Utilities and Costs for Multiple Sclerosis
09
10
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
v. 1, no. 1 (1998)20011126 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper